Back to Pt-141 research
pt-141 melanocortin agonist review 2026-04-03 PubMed

Expert Review: Current and Future Drugs for Female Sexual Dysfunction

Expert opinion on existing and developing drugs to treat female sexual dysfunction.

Background

Female Sexual Dysfunction (FSD) is a prevalent and often undertreated condition impacting millions of women globally, significantly affecting quality of life and relationships. Despite its widespread impact, effective pharmacological treatments remain limited, leading to a substantial unmet medical need. This expert opinion reviews the current landscape and emerging pharmacological strategies for managing FSD, highlighting both approved and investigational therapies.


pt-141 melanocortin agonist
Source: pubmed:30251897 · Ingested 2026-04-03 · Digest: gemini-2.5-flash